Neurofilament light chain (NFL) and glial fibrillary acidic protein (GFAP) have been proposed as potential biomarkers for DLB or FTD, but those are more likely to be general neurodegenerative markers rather than disease-specific. This evidence concerns the gene NEFL and frontotemporal dementia.